China NMPA Product Recall - DxI 9000 Access Immunoassay Analyzer

The National Medical Products Administration (NMPA) in China has announced a voluntary Class II recall initiated by Beckman Coulter, Inc. for its DxI 9000 Access Immunoassay Analyzer. This recall was officially reported by Beckman Coulter Trading (China) Co., Ltd. on April 3, 2025. The core issue prompting this action is a critical communication failure identified between the analyzer and its associated host system, which could potentially impact the device's performance and reliability. While specific details, including the affected batch numbers, are referenced in the comprehensive "Medical Device Recall Event Report Form" provided by Beckman Coulter (USA) Corporation, an important clarification has been made: none of the products subject to this recall were imported into or distributed within the Chinese market. This indicates a proactive and responsible measure taken by the manufacturer to address a potential defect globally, aligning with the stringent regulatory oversight of the NMPA. The Class II designation signifies that the use of or exposure to the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. This action underscores the ongoing commitment to ensure the safety and efficacy of medical devices worldwide.